Research Advances in Antimicrobial Stewardship, Residues and Resistance in Veterinary and Environmental Science

Dear Colleagues,

Antimicrobial resistance (AMR) threatens human, animal, and environmental health, underscoring the need for advancing antimicrobial stewardship (AMS) in the veterinary sciences. This Special Issue highlights cutting-edge research that addresses this global challenge from a veterinary science perspective, considering critical facets of AMR, including antimicrobial residues (ARs) and AMS’ effect on animal health.

Contributions to this Special Issue may explore at-risk epidemiological groups, novel diagnostic tools, innovative therapeutic approaches, and integrated management strategies for reducing antimicrobial use while maintaining animal welfare and productivity. Studies could also focus on the environmental and public health dimensions of ARs in agricultural systems, presenting data-driven approaches to mitigate their impacts on human health and ecosystems.

Insights from studies on interdisciplinary and transectoral collaborations should demonstrate how coordinated efforts across veterinary, medical, and environmental sectors can strengthen stewardship practices to achieve a One Health outcome. This Special Issue also features case studies showcasing the successful implementation of antimicrobial stewardship programs in diverse veterinary and environmental contexts, as well as policy-focused analyses offering frameworks for sustainable, cross-sectoral AMR and AR mitigation strategies.

By bridging research, practice and policy, this Special Issue provides a comprehensive collection of studies showcasing the latest methodological advancements, operational challenges, and policy opportunities for combating AMR and ARs. Studies included in this Special Issue will serve as an important resource for veterinarians, researchers, policymakers, and environmental industry stakeholders committed to safeguarding the efficacy of antimicrobials for animal patients and the community.

Dr. Justine S. Gibson
Dr. Ricardo Magalhães
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.